2nd Annual Gene Therapy for ophthalmic Disorders, digital event

5th Annual Cell & Gene Therapy World Asia, virtual

Clinical Trials in Rare Diseases Conference 2021, Europe and USA, virtual conference

GenSight Biologics Announces Publication Analyzing Visual Parameters of ND4-LHON Subjects before LUMEVOQ® treatment in Phase III Trials

Ophthalmology Futures Forums – Euro Retina Virtual Forum, September 8, 2021

UK MHRA grants GenSight Biologics’ LUMEVOQ® ophthalmic gene therapy Promising Innovative Medicine designation

Clinical Data on GenSight Biologics’ LUMEVOQ® and GS030 Gene Therapies to be Presented at 2021 ISGEDR and Several Investor and Industry Meetings in September

GenSight Biologics Reports Interim Financial Results for the First Half of 2021 and Provides Operational Update

OIS European Innovation Showcase – Virtual

French Retail Investors Webcast on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®